ImPact Biotech Announces Appointment of Eyal Morag, M.D. as
TEL AVIV, Israel, Dec. 18, 2023 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin Vascular...
Source: globenewswire.com
Pact Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pact Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pact Biotech Today - Breaking & Trending Today
ImPact Biotech Announces Research Collaboration to develop
ImPact Biotech to collaborate with Maastricht University researchers to develop a treatment to arrest the progressive condition Pathologic Myopia, a...
Source: globenewswire.com
FDA Grants Orphan Drug Designation to Padeliporfin VTP for Pancreatic Cancer
The FDA has granted orphan drug designation to padeliporfin vascular targeted photodynamic therapy for use as a potential therapeutic option in patients with locally advanced pancreatic cancer.
Source: onclive.com